HomeCompareJNJ vs ORAN

JNJ vs ORAN: Dividend Comparison 2026

JNJ yields 3.36% · ORAN yields 7.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ORAN wins by $14.1K in total portfolio value
10 years
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →
ORAN
ORAN
● Live price
7.00%
Share price
$11.15
Annual div
$0.78
5Y div CAGR
2.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$1,544.09
Full ORAN calculator →

Portfolio growth — JNJ vs ORAN

📍 ORAN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJNJORAN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JNJ + ORAN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JNJ pays
ORAN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
ORAN
Annual income on $10K today (after 15% tax)
$594.62/yr
After 10yr DRIP, annual income (after tax)
$1,312.48/yr
At 15% tax rate, ORAN beats the other by $608.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JNJ + ORAN for your $10,000?

JNJ: 50%ORAN: 50%
100% ORAN50/50100% JNJ
Portfolio after 10yr
$27.1K
Annual income
$1,185.94/yr
Blended yield
4.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
ORAN
Analyst Ratings
5
Buy
8
Hold
1
Sell
Consensus: Hold
Altman Z
1.3
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JNJ buys
0
ORAN buys
0
No recent congressional trades found for JNJ or ORAN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJNJORAN
Forward yield3.36%7.00%
Annual dividend / share$4.96$0.78
Payout ratio55%50%
1-year div growth4.2%0%
5-year div CAGR5.8%2.9%
Portfolio after 10y$20.0K$34.2K
Annual income after 10y$827.78$1,544.09
Total dividends collected$5.6K$11.0K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold

Year-by-year: JNJ vs ORAN ($10,000, DRIP)

YearJNJ PortfolioJNJ Income/yrORAN PortfolioORAN Income/yrGap
1← crossover$10,676$355.77$11,420$719.84$744.00ORAN
2$11,407$389.39$13,010$790.55$1.6KORAN
3$12,198$426.53$14,787$866.10$2.6KORAN
4$13,056$467.62$16,768$946.67$3.7KORAN
5$13,987$513.12$18,974$1,032.40$5.0KORAN
6$14,998$563.56$21,426$1,123.47$6.4KORAN
7$16,098$619.52$24,146$1,220.03$8.0KORAN
8$17,295$681.69$27,158$1,322.21$9.9KORAN
9$18,599$750.82$30,490$1,430.19$11.9KORAN
10$20,022$827.78$34,168$1,544.09$14.1KORAN

JNJ vs ORAN: Complete Analysis 2026

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

ORANStock

Orange S.A. provides various fixed telephony and mobile telecommunications, data transmission, and other value-added services to customers, businesses, and other telecommunications operators in France and internationally. It operates through France; Spain and Other European Countries; The Africa and Middle East; Enterprise; International Carriers & Shared Services; and Mobile Financial Services segments. The company offers mobile services, such as voice, SMS, and data; fixed broadband and narrowband services, as well as fixed network business solutions, including voice and data; and convergence packages. It also sells mobile handsets, mobile terminals, broadband equipment, connected devices, and accessories. In addition, the company provides IT and integration services comprising unified communication and collaboration services, such as LAN and telephony, consultancy, integration, and project management; hosting and infrastructure services, including cloud computing; customer relations management and other applications services; security services; and video conferencing, as well as sells related equipment. Further, it offers national and international roaming services; online advertising services; and mobile virtual network operators, network sharing, and mobile financial services, as well as sells equipment to external distributors and brokers. Orange S.A. markets its products and services under the Orange brand. The company was formerly known as France Telecom and changed its name to Orange S.A. in July 2013. Orange S.A. was founded in 1990 and is headquartered in Issy-les-Moulineaux, France.

Full ORAN Calculator →
📬

Get this JNJ vs ORAN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JNJ vs ABBVJNJ vs MRKJNJ vs PFEJNJ vs BMYJNJ vs LLYJNJ vs SCHDJNJ vs JEPIJNJ vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.